EUVIMEDEUVIMED entdecken
LeserbriefSystematische Übersicht

Comment on: Incidence rate of osteonecrosis of jaw after cancer treated with bisphosphonates and denosumab: A systematic review and meta‐analysis

Efsun Somay iD

Special Care in Dentistry · 2024

DOI: 10.1111/scd.12909 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Special Care in Dentistry, 2024. Verfasst von Efsun Somay. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Baskent University, Ankara, Turkey. Hauptthemen laut MEDLINE: Bisphosphonate-Associated Osteonecrosis of the Jaw, Bone Density Conservation Agents, Denosumab, Diphosphonates. Die Arbeit nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bisphosphonate-Associated Osteonecrosis of the JawBone Density Conservation AgentsDenosumabDiphosphonatesHumansIncidenceNeoplasmsOsteonecrosisSystematic Reviews as TopicMeta-Analysis as Topic

Substanzen

Bone Density Conservation AgentsDenosumabDiphosphonates

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Baskent University, Ankara, Turkey.

ORCID-Profile: Efsun Somay

Zitieren

APA

Somay, E. (2024). Comment on: Incidence rate of osteonecrosis of jaw after cancer treated with bisphosphonates and denosumab: A systematic review and meta‐analysis. Special Care in Dentistry. https://doi.org/10.1111/scd.12909

Vancouver

Somay E. Comment on: Incidence rate of osteonecrosis of jaw after cancer treated with bisphosphonates and denosumab: A systematic review and meta‐analysis. Special Care in Dentistry. 2024. doi:10.1111/scd.12909

BibTeX
@article{Somay2024,
  author = {Somay, Efsun},
  title = {Comment on: Incidence rate of osteonecrosis of jaw after cancer treated with bisphosphonates and denosumab: A systematic review and meta‐analysis},
  journal = {Special Care in Dentistry},
  year = {2024},
  doi = {10.1111/scd.12909}
}
Kostenlos starten →